tiprankstipranks
Trending News
More News >
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market

CG Oncology, Inc. (CGON) Ratios

Compare
164 Followers

CG Oncology, Inc. Ratios

CGON's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, CGON's free cash flow was decreased by $ and operating cash flow was $-811.62. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
9.54 13.62 9.54 9.78
Quick Ratio
9.54 13.62 9.54 9.78
Cash Ratio
5.71 0.58 5.71 8.97
Solvency Ratio
-1.57 -3.35 -1.57 -0.70
Operating Cash Flow Ratio
-1.93 -3.20 -1.93 -2.29
Short-Term Operating Cash Flow Coverage
-3.32 0.00 -3.32 -4.64
Net Current Asset Value
$ 124.64M$ 179.61M$ 124.64M$ 39.97M
Leverage Ratios
Debt-to-Assets Ratio
0.11 <0.01 0.11 0.26
Debt-to-Equity Ratio
0.13 <0.01 0.13 0.38
Debt-to-Capital Ratio
0.12 <0.01 0.12 0.28
Long-Term Debt-to-Capital Ratio
0.05 0.00 0.05 0.23
Financial Leverage Ratio
1.18 1.08 1.18 1.46
Debt Service Coverage Ratio
-3.93 0.00 -3.93 -3.65
Interest Coverage Ratio
-35.25K 0.00 -35.25K -27.95
Debt to Market Cap
<0.01 0.00 <0.01 <0.01
Interest Debt Per Share
0.24 <0.01 0.24 0.24
Net Debt to EBITDA
2.04 0.14 2.04 3.08
Profitability Margins
Gross Profit Margin
92.15%100.00%92.15%99.90%
EBIT Margin
-18453.40%-27180.88%-18453.40%-119.60%
EBITDA Margin
-18445.55%-27172.55%-18445.55%-119.50%
Operating Profit Margin
-18453.40%-27180.88%-18453.40%-121.70%
Pretax Profit Margin
-18556.54%-23826.96%-18556.54%-123.95%
Net Profit Margin
-18556.54%-23826.96%-18556.54%-123.95%
Continuous Operations Profit Margin
-18556.54%-23826.96%-18556.54%-123.95%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
100.56%87.66%100.56%101.85%
Return on Assets (ROA)
-23.99%-24.39%-23.99%-21.88%
Return on Equity (ROE)
-28.31%-26.30%-28.31%-31.90%
Return on Capital Employed (ROCE)
-26.64%-29.96%-26.64%-23.91%
Return on Invested Capital (ROIC)
-24.91%-29.93%-24.91%-22.62%
Return on Tangible Assets
-23.99%-24.39%-23.99%-21.88%
Earnings Yield
-1.43%-1.96%-1.43%-0.52%
Efficiency Ratios
Receivables Turnover
0.63 2.22 0.63 5.18K
Payables Turnover
0.02 0.00 0.02 <0.01
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.38 0.42 0.38 51.79
Asset Turnover
<0.01 <0.01 <0.01 0.18
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 0.00
Cash Conversion Cycle
-23.39K 164.61 -23.39K -36.61K
Days of Sales Outstanding
579.03 164.61 579.03 0.07
Days of Inventory Outstanding
0.00 0.00 0.00 0.00
Days of Payables Outstanding
23.97K 0.00 23.97K 36.61K
Operating Cycle
579.03 164.61 579.03 0.07
Cash Flow Ratios
Operating Cash Flow Per Share
-0.45 -0.69 -0.45 -0.20
Free Cash Flow Per Share
-0.45 -0.69 -0.45 -0.21
CapEx Per Share
<0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-2.13K 0.00 -2.13K -140.76
Capital Expenditure Coverage Ratio
-2.13K 0.00 -2.13K -140.76
Operating Cash Flow Coverage Ratio
-1.83 -99.09 -1.83 -0.88
Operating Cash Flow to Sales Ratio
-156.04 -223.92 -156.04 -1.32
Free Cash Flow Yield
-1.20%-1.84%-1.20%-0.56%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-69.88 -50.96 -69.88 -192.92
Price-to-Sales (P/S) Ratio
12.97K 12.14K 12.97K 239.13
Price-to-Book (P/B) Ratio
19.79 13.40 19.79 61.53
Price-to-Free Cash Flow (P/FCF) Ratio
-83.07 -54.22 -83.07 -180.12
Price-to-Operating Cash Flow Ratio
-83.11 -54.22 -83.11 -181.40
Price-to-Earnings Growth (PEG) Ratio
-0.39 -1.35 -0.39 0.00
Price-to-Fair Value
19.79 13.40 19.79 61.53
Enterprise Value Multiple
-68.26 -44.54 -68.26 -197.02
Enterprise Value
2.41B 2.47B 2.41B 2.44B
EV to EBITDA
-68.26 -44.54 -68.26 -197.02
EV to Sales
12.59K 12.10K 12.59K 235.45
EV to Free Cash Flow
-80.66 -54.05 -80.66 -177.35
EV to Operating Cash Flow
-80.69 -54.05 -80.69 -178.61
Tangible Book Value Per Share
1.88 2.77 1.88 0.60
Shareholders’ Equity Per Share
1.88 2.77 1.88 0.60
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 0.16
Net Income Per Share
-0.53 -0.73 -0.53 -0.19
Tax Burden
1.00 1.00 1.00 1.00
Interest Burden
1.01 0.88 1.01 1.04
Research & Development to Revenue
151.98 224.27 151.98 1.77
SG&A to Revenue
33.55 48.53 33.55 0.45
Stock-Based Compensation to Revenue
3.54 7.49 3.54 0.11
Income Quality
0.84 0.94 0.84 1.06
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis